News

Transcend Therapeutic announces breakthrough therapy designation for TSND-201 for treating PTSD.

Learn more about how serum drug levels enhance psychiatric treatment by providing critical insights into medication efficacy and patient outcomes.

The psychological impact of national tragedies: it's time to recognize the importance of mourning and finding meaning in collective grief.

A groundbreaking study links antibiotic exposure to increased depression risk in adolescents, highlighting urinary analysis as a potential screening tool.

This book explores how mistrust and disinformation shape our beliefs, revealing the psychological mechanisms behind false convictions in today's society.

How can we teach psychopharmacology in a way that engages today's digital-native psychiatry residents and enhances real-world application?

Long COVID presents complex symptoms without clear diagnostic criteria, challenging traditional medical understanding and emphasizing the need for compassionate care.

Johnson & Johnson has submitted an sNDA for Caplyta, showcasing significant relapse prevention in schizophrenia.

Anna Ornstein, MD's legacy as a Holocaust survivor and humanitarian psychiatrist inspires reflection on societal issues and the importance of empathy in healing.

The debate over palliative psychiatry's role in advocating for psychiatric euthanasia continues, raising ethical concerns about mental health care and patient autonomy.

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

GLP-1 receptor agonists emerge as potential game-changers in psychiatric treatment, targeting mental disorders and improving cognitive function.

This heartfelt tribute poem to Dr Jessica Obeysekare celebrates her passion, empathy, and dedication in both life and academia.

An interdisciplinary gathering at the 2025 virtual conference of the Society for Digital Mental Health heard presentations and panel discussions on digital therapeutics, along with reports of studies on the technology and outcomes by student and young researchers.

Let's look at the intersection of psychiatry and the afterlife, including the beliefs, research, and personal insights on reincarnation and purpose.

Explore the transformative power of self-compassion through poetry, mentorship, and shared humanity in overcoming doubt and anxiety.

Roger S. McIntyre, MD, FRCPC, shares the backstory and pharmacology of incretins to better understand the role of GLP-1 RAs in psychiatry.

New research reveals ketamine's safe use for treating eating disorders, offering hope for patients with comorbid treatment-resistant depression.

Researchers analyze single-cell communication in brains of people with PTSD, uncovering genetic variations that could lead to new treatments for this complex disorder.

Explore essential insights and best practices in geriatric psychiatry in our July theme! Submit your insights, tips, and case studies centered on healthy aging for older adults.

These 2 compelling memoirs delve into the complexities of schizophrenia, showcasing resilience, friendship, and the impact of mental health.

New clinical trial results reveal BPL-003's rapid and durable antidepressant effects, paving the way for innovative treatments in treatment-resistant depression.

The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals.

Doctors in India face escalating burnout and violence, risking their well-being while navigating a broken health care system. This Doctor's Day, reform is urgently needed.

New research reveals how ezogabine targets potassium channels in the brain, offering innovative treatment options for major depressive disorder symptoms.

Discover how PAs like Erin Crown, MHS, PA-C, Psych-CAQ, are transforming mental health care, bridging gaps, and expanding access to psychiatric services nationwide.

Check out the pipeline updates from June!

Alto Neuroscience's ALTO-203 trial reveals mixed results, highlighting potential biomarkers for targeted depression treatment despite missing primary efficacy goals.

Explore the intriguing connections between afterlife beliefs, personal experiences, and the psychological impact of grief in this thought-provoking analysis.

Researchers uncover a novel biomarker for major depressive disorder, linking regional homogeneity in fMRI to decreased cerebral blood flow and symptom severity.